Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Carbon Tetrachloride. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbon Tetrachloride SCHEMBL8402265 | 0.95 | TSHR (0.40) | LMNATSHRALDH1A1CYP2E1THRB | |
| Chloroform SCHEMBL28063298 | 0.85 | LMNA (0.50) | LMNATSHRALDH1A1 | |
| Chloroform SCHEMBL27706310 | 0.85 | LMNA (0.50) | LMNATSHRALDH1A1 | |
| Carbon Tetrachloride SCHEMBL27838684 | 0.85 | LMNA (0.50) | LMNATSHRALDH1A1CYP2E1 | |
| Chloroform SCHEMBL9617984 | 0.85 | LMNA (0.50) | LMNATSHRALDH1A1 | |
| Chloroform SCHEMBL25447 | 0.85 | — | — | |
| Carbon Tetrachloride SCHEMBL27802885 | 0.85 | — | — | |
| Chloroform SCHEMBL28040546 | 0.85 | — | — | |
| Chloroform SCHEMBL8907442 | 0.85 | LMNA (0.50) | LMNATSHRALDH1A1 | |
| Chloroform SCHEMBL28176439 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102093325-B | The preparation method of a kind of high purity dinatin and herba lycopi flavone | SHANGHAI TAUTO BIOTECH CO., LTD. (CN) | 2015-08-05 | — | — | CN | claimed |
| CN-102093325-A | Method for preparing high-purity hispidulin and herba lycopi flavone | SHANGHAI TAUTO BIOTECH CO LTD | 2011-06-15 | — | — | CN | claimed |
| CN-102093325-B | The preparation method of a kind of high purity dinatin and herba lycopi flavone | SHANGHAI TAUTO BIOTECH CO., LTD. (CN) | 2015-08-05 | — | — | CN | disclosed |
| CN-102093325-A | Method for preparing high-purity hispidulin and herba lycopi flavone | SHANGHAI TAUTO BIOTECH CO LTD | 2011-06-15 | — | — | CN | disclosed |
| EP-0923594-B1 | BROMOTIACUMICIN COMPOUNDS | ABBOTT LAB (US) | 2002-10-02 | — | — | EP | disclosed |
| US-5767096-A | PRODUCED BY CULTURING DACTYLOSPORANGIUM IN A BROMIDE ENRICHED NUTRIENT MEDIUM | ABBOTT LABORATORIES (US) | 1998-06-16 | — | — | US | disclosed |
| US-4780416-A | BACTERICIDES, ANTITUMOR AGENTS | BRISTOL-MYERS COMPANY (US) | 1988-10-25 | — | — | US | disclosed |
| US-4631256-A | FROM ACTINOMYCIN-ANTIBIOTIC, ANTITUMOR AGENT | BRISTOL-MYERS COMPANY (US) | 1986-12-23 | — | — | US | disclosed |
| US-4451456-A | Antitumor antibacterial agents | BRISTOL-MYERS COMPANY (US) | 1984-05-29 | — | — | US | disclosed |
| US-4360458-A | PEPTIDE ANTIBIOTICS, ANTIBIOTIC BBM-928 | BRISTOL-MYERS COMPANY (US) | 1982-11-23 | — | — | US | disclosed |
| US-3981862-A | Preparation of C22-alkyl derivative of digoxin | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-09-21 | — | — | US | disclosed |
| US-3947404-A | CARDIAC THERAPY | BOEHRINGER MANNHEIM GMBH (DT) | 1976-03-30 | — | — | US | disclosed |